GlassScriptPhysician profile
Lauren Chinn
NPI 1588118673
$2,102.76
in general payments reported to CMS, 2019-2025
13 companies · $48.16 in 2025
The $48.16 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,295 · 2023: $594 · 2024: $165 · 2025: $48.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,279.11 | 2021 | |
| Abbvie INC. | $435.30 | 2023 | |
| Myriad Genetic Laboratories, INC. | $144.53 | 2023 | Myrisk |
| Polynovo North America LLC | $51.32 | 2024 | Novosorb Btm |
| Axogen | $39.31 | 2024-2025 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector |
| Endo USA, INC. | $29.69 | 2025 | Xiaflex |
| Elucent Medical | $23.00 | 2024 | |
| Hologic Sales and Service, LLC | $20.70 | 2024 | Trunode, Localizer |
| Becton, Dickinson and Company | $18.55 | 2024 | Trek |
| Cumberland Pharmaceuticals, INC. | $16.32 | 2024 | Caldolor |
| Endo Pharmaceuticals INC. | $16.12 | 2021 | |
| Tactile Systems Technology INC | $14.41 | 2024 | Flexitouch Plus, Entre Plus |
| Integra Lifesciences Corporation | $14.40 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Chinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.